JAMA Network podcast

JAMA Oncology : Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma

24/10/2024
0:00
20:41
Manda indietro di 15 secondi
Manda avanti di 15 secondi

Interview with Maria E. Cabanillas, MD, author of Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma: A Nonrandomized Clinical Trial. Hosted by Vivek Subbiah, MD.

Related Content:

Altri episodi di "JAMA Network"